MesenFlow delivers human tissue-based platforms that model inflammation under physiological flow. We provide faster, cost-efficient and animal-free preclinical insights into compound safety, efficacy and mechanism of action. We help pharma and biotech increase predictive accuracy and reduce development risk across inflammation, oncology and toxicology, supporting more informed decisions and accelerating the development of safer, more effective therapies.
